Dag Hoem
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 20
- Surgery top 5%
- Pancreatic function and diabetes 11
- Pancreatitis Pathology and Treatment 5
- Cancer Research top 10%
- Biomedical Engineering top 5%
-
- Gallbladder and Bile Duct Disorders 6
- Biliary and Gastrointestinal Fistulas 4
-
- Neuroendocrine Tumor Research Advances 6
-
- Metabolism, Diabetes, and Cancer 6
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- Anders MolvenGeorg DimcevskiOdd Helge GiljaHeike ImmervollMichiel PostemaSpiros KotopoulisAsgaut VisteÅke Andrén‐Sandberg
- Cited by
- OncologySurgeryCancer Research
- Journals
- Scandinavian Journal of Surgery (3 papers)Annals of Oncology (3 papers)Pancreatology (3 papers)
- Partner nations
- NorwayUnited StatesSweden
In The Last Decade
Dag Hoem
37 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 701
- Surgery 621
- Cancer Research 178
- Biomedical Engineering 504
- Pulmonary and Respiratory Medicine 300
Countries citing papers authored by Dag Hoem
This map shows the geographic impact of Dag Hoem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dag Hoem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dag Hoem more than expected).
Fields of papers citing papers by Dag Hoem
This network shows the impact of papers produced by Dag Hoem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dag Hoem. The network helps show where Dag Hoem may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dag Hoem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 12 | |
| 2 | 2017 | 8 | |
| 3 | 2017 | 14 | |
| 4 | 2017 | 26 | |
| 5 | 2017 | 4 | |
| 6 | A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancerbreakdown → | 2016 | 359 |
| 7 | 2015 | 42 | |
| 8 | 2015 | 23 | |
| 9 | 2015 | 25 | |
| 10 | 2013 | 28 | |
| 11 | 2013 | 184 | |
| 12 | 2012 | 23 | |
| 13 | 2011 | 74 | |
| 14 | 2008 | 175 | |
| 15 | Epidemiology and risk factors for exocrine pancreatic cancer | 2007 | 4 |
| 16 | 2006 | 78 | |
| 17 | 2002 | 13 | |
| 18 | 2002 | 74 | |
| 19 | 2002 | 17 | |
| 20 | 1999 | 15 |
About Dag Hoem
Dag Hoem is a scholar working on Oncology, Surgery, Hepatology, Anesthesiology and Pain Medicine and Cancer Research, having authored 37 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (20 papers), Pancreatic function and diabetes (11 papers), Neuroendocrine Tumor Research Advances (6 papers), Gallbladder and Bile Duct Disorders (6 papers), Metabolism, Diabetes, and Cancer (6 papers), Pancreatitis Pathology and Treatment (5 papers), Biliary and Gastrointestinal Fistulas (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Oncology (701 citations), Surgery (621 citations), Cancer Research (178 citations), Biomedical Engineering (504 citations) and Pulmonary and Respiratory Medicine (300 citations). Dag Hoem has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Anders Molven, Georg Dimcevski, Odd Helge Gilja, Heike Immervoll, Michiel Postema, Spiros Kotopoulis, Asgaut Viste, Åke Andrén‐Sandberg, Halfdan Sørbye and Per Øystein Sakariassen. Their work appears in journals such as Scandinavian Journal of Surgery, Annals of Oncology, Pancreatology, BMC Cancer and Pancreas.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.